+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Kura Oncology Inc - logo
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 4011 Pages
From
Acute Myeloid Leukaemia - Pipeline Insight, 2021 - Product Thumbnail Image

Acute Myeloid Leukaemia - Pipeline Insight, 2021

  • Clinical Trials
  • December 2021
  • 200 Pages
From
RAS Targeting Therapies by Target Indication, Type of Molecule, Type of Therapy, and Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2031 - Product Thumbnail Image

RAS Targeting Therapies by Target Indication, Type of Molecule, Type of Therapy, and Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2031

  • Report
  • July 2021
  • 545 Pages
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2020 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3103 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • May 2018
  • 1275 Pages
From
New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030 - Product Thumbnail Image

New Frontiers in Cancer Therapies: Focus on Transcription Factors, GTPases, Phosphatases and GPCRs, 2018-2030

  • Report
  • May 2018
  • 200 Pages
From
2019 Hepatitis D Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Hepatitis D Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 80 Pages
From
Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 201 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 (ERT2 or Insulin Stimulated MAP2 Kinase or Extracellular Signal Regulated Kinase 1 or MAP Kinase Isoform p44 or Microtubule Associated Protein 2 Kinase or p44 ERK1 or MAPK3 or EC 2.7.11.24) - Pipeline Review, H2 201

  • Drug Pipelines
  • August 2018
  • 56 Pages
From
FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2022 - Product Thumbnail Image

FTase (Farnesyltransferase) inhibitor- Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

T-Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • September 2021
  • 102 Pages
From
Large Volume Wearable Injectors Market by Type of Device, Usability, Therapeutic Area, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035 - Product Thumbnail Image

Large Volume Wearable Injectors Market by Type of Device, Usability, Therapeutic Area, Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2035

  • Report
  • November 2021
  • 402 Pages
From
Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 - Product Thumbnail Image

Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

  • Report
  • October 2019
  • 302 Pages
From
Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices - Product Thumbnail Image

Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices

  • Report
  • May 2020
  • 550 Pages
From
T-Cell Lymphoma - Pipeline Insight, 2021 - Product Thumbnail Image

T-Cell Lymphoma - Pipeline Insight, 2021

  • Drug Pipelines
  • July 2021
  • 200 Pages
From
Mitogen Activated Protein Kinase 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Mitogen Activated Protein Kinase 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 68 Pages
From
Mitogen Activated Protein Kinase 3 - Pipeline Review, H2 2019 - Product Thumbnail Image

Mitogen Activated Protein Kinase 3 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 64 Pages
From
Peripheral T-Cell Lymphoma (PTCL) - Pipeline Insight, 2020 - Product Thumbnail Image

Peripheral T-Cell Lymphoma (PTCL) - Pipeline Insight, 2020

  • Clinical Trials
  • October 2020
  • 100 Pages
From
Global Pancreatic Cancer Drugs Market 2020-2026 - Product Thumbnail Image

Global Pancreatic Cancer Drugs Market 2020-2026

  • Report
  • May 2020
From
Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2020 - Product Thumbnail Image

Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2020

  • Clinical Trials
  • November 2020
  • 40 Pages
From
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2018 - Product Thumbnail Image

Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 2.7.11.24) - Pipeline Review, H2 2018

  • Drug Pipelines
  • August 2018
  • 59 Pages
From
Loading Indicator